Point State Capital LP Vertex Pharmaceuticals Inc Transaction History

Point State Capital LP

$4.56 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $3.87 Million - $4.57 Million	-17,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $3.1 Million - $3.91 Million	17,500 New	17,500 $3.84 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $9.07 Million - $10.1 Million	-50,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $1.59 Million - $1.85 Million	7,659 Added 18.09%	50,000 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $8.77 Million - $11.7 Million	42,341 New	42,341 $10 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $1.92 Million - $2.51 Million	-8,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $1.7 Million - $2.11 Million	8,500 New	8,500 $2.02 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $1.4 Million - $1.57 Million	-8,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $938,277 - $1.09 Million	5,700 Added 211.11%	8,400 $1.54 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $442,071 - $525,690	2,700 New	2,700 $497,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $131 Million - $150 Million	-779,200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $70 Million - $81.7 Million	480,523 Added 160.88%	779,200 $132 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $41.8 Million - $48.8 Million	-275,613 Reduced 47.99%	298,677 $48.7 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $14 Million - $15.8 Million	101,690 Added 21.52%	574,290 $86.1 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $58 Million - $63.5 Million	391,300 Added 481.3%	472,600 $71.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	81,300	81,300 $10.5 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Account